Sinha Vikas's Form 4 filing
Kalaris Therapeutics, Inc. (KLRS) · filed Jul 23, 2024
- Accession no.
- 0000950170-24-085663
- Filed
- Jul 23, 2024
- Trade date
- Jul 19-22, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.53K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinha VikasCIK 0001337845 | Director, Officer (See Remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | Common Stock | SSaleDisposed | −1,542 | $0.75 | −$1,156.5 | 1,163,852 | Direct | |
| Jul 22, 2024 | Common Stock | SSaleDisposed | −1,858 | $0.74 | −$1,374.92 | 1,161,994 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.